HealthEquity, Inc.
HQY · NASDAQ
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 20% | 16% | 13.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 64.8% | 62.3% | 56.9% | 56% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 13.5% | 12.8% | 4.5% | 4.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 8.1% | 5.6% | -3% | -5.9% |
| EPS | 1.11 | 0.65 | -0.31 | -0.53 |
| % Growth | 70.8% | 309.7% | 41.5% | – |
| EPS Diluted | 1.09 | 0.64 | -0.31 | -0.53 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.1% | 28.3% | 19.9% | 13.6% |